Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Russ Kuker"'
Autor:
Muhammad Husnain, Russ Kuker, Isildinha M. Reis, Sunil Girish Iyer, Wei Zhao, Jennifer R. Chapman, Francisco Vega, Izidore S. Lossos, Juan Pablo Alderuccio
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5051-5064 (2020)
Abstract Pulmonary marginal zone lymphoma (PMZL) is the most common non‐Hodgkin lymphoma affecting the lung. PMZL is usually an indolent disease. Clinical and radiological variables associated with shorter survival are largely unknown and no consen
Externí odkaz:
https://doaj.org/article/618fc7be8d2c411bb8f0203805b99796
Autor:
John Manov, BS, Michael Langston, BS, Patrick Roth, MD, Jodie Barkin, MD, Russ Kuker, MD, Jamie S. Barkin, MD
Publikováno v:
Radiology Case Reports, Vol 13, Iss 1, Pp 72-75 (2018)
Pancreatic cancer is often detected in late stages, which contributes to its grim prognosis. Although the manifestations of pancreatic cancer most often include nonspecific gastrointestinal complaints, we report a case with the sole initial complaint
Externí odkaz:
https://doaj.org/article/d44768a2faaf4ead836203573a93a1b8
Publikováno v:
Case Reports in Endocrinology, Vol 2018 (2018)
The coexistence of thyroid functioning nodules and Graves’ disease is called Marine-Lenhart syndrome. This condition is estimated to occur in 0.8-2.7% of patients with Graves’ disease with few cases reported in the literature. Criteria for the di
Externí odkaz:
https://doaj.org/article/c44e399dfc1841fe8a903626c491dd25
Publikováno v:
Clinical Nuclear Medicine. 48:e225-e227
Autor:
Samy Castillo-Flores, Marcos R. Gonzalez, Mayte Bryce-Alberti, Felipe de Souza, Ty K. Subhawong, Russ Kuker, Juan Pretell-Mazzini
Publikováno v:
JBJS Reviews. 10
Autor:
Juan Pablo Alderuccio, Thomas Habermann, Russ Kuker, Craig H. Moskowitz, Andrew D. Zelenetz, Izidore S. Lossos
Publikováno v:
American journal of hematology. 97(11)
Marginal zone lymphoma (MZL) is commonly underrepresented in clinical trials collectively studying mostly nodal indolent lymphomas.In this manuscript we propose new inclusion and response criteria defined by MZL subtype and disease location for those
Autor:
Manuel Lora Gonzalez, Charif Sidani, Atil Y. Kargi, Marilyn A. Arosemena, Sabina Casula, Maria I. Linares Linares Valderrama, Rosa P. Castillo, Anu Thekkumkattil, Russ Kuker
Publikováno v:
Endocrines, Vol 2, Iss 9, Pp 91-98 (2021)
Endocrines
Volume 2
Issue 2
Pages 9-98
Endocrines
Volume 2
Issue 2
Pages 9-98
Background: Substantial inter-observer variation has been documented in the recognition and description of specific sonographic features as well as for ATA sonographic risk (ASR). This raises the question if the risk stratification proposed by the AT
Autor:
Maria I. Linares Linares Valderrama, Atil Y. Kargi, Manuel Lora Gonzalez, Marilyn A. Arosemena, Sabina Casula, Anu Thekkumkattil, Rosa P. Castillo, Charif Sidani, Russ Kuker
Publikováno v:
Thyroid. 30:1613-1619
Background: The Afirma gene expression classifier (GEC) has been used to aid in the diagnosis and management of thyroid nodules having Bethesda category III fine-needle aspiration cytologic diagnosis (B3 nodules). The American Thyroid Association son
Autor:
Jennifer R. Chapman, Juan Pablo Alderuccio, Jorge A. Florindez, Eduardo Edelman Saul, Russ Kuker, Asaad Trabolsi, Gregor A. Rodriguez, Sunil Iyer, Izidore S. Lossos
Publikováno v:
Leukemialymphoma. 63(3)
Breast extranodal marginal zone lymphoma (EMZL) is a rare malignancy. We performed the largest published to date single-center retrospective analysis of 13 patients with breast EMZL focusing on clinical characteristics and treatment-related outcomes.
Autor:
Mike Georgiou, Russ Kuker, Matthew T. Studenski, Megan Witte, Lorraine Portelance, Preeti P. Ahlman
Publikováno v:
EJNMMI Research
EJNMMI Research, Vol 11, Iss 1, Pp 1-10 (2021)
EJNMMI Research, Vol 11, Iss 1, Pp 1-10 (2021)
Background 99mTc-macroaggregated albumin (99mTc-MAA) scintigraphy is utilized in treatment planning for Yttrium-90 (90Y) Selective Internal Radiation Therapy (SIRT) of liver tumors to evaluate hepatopulmonary shunting by calculating the lung shunt fr